These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

981 related items for PubMed ID: 18945417

  • 1. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 2. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, Parkin DM, Qiao YL, Sankaranarayanan R, Stern PL, Tay SK, Bosch FX.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [Abstract] [Full Text] [Related]

  • 4. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, Clifford GM, Franceschi S.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [Abstract] [Full Text] [Related]

  • 7. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M, Jasani B, Fiander A.
    Vaccine; 2007 Apr 20; 25(16):3007-13. PubMed ID: 17292517
    [Abstract] [Full Text] [Related]

  • 8. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ, Diaz M, Kim SY, Levin CE, Van Minh H, Kim JJ.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [Abstract] [Full Text] [Related]

  • 9. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I.
    Klin Mikrobiol Infekc Lek; 2006 Jun 19; 12(3):91-7. PubMed ID: 17051469
    [Abstract] [Full Text] [Related]

  • 10. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.
    Med Klin (Munich); 2007 Jul 15; 102(7):515-23. PubMed ID: 17634869
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP.
    PLoS Med; 2006 May 15; 3(5):e138. PubMed ID: 16573364
    [Abstract] [Full Text] [Related]

  • 12. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M.
    Cancer; 2007 Jun 25; 111(3):145-53. PubMed ID: 17487850
    [Abstract] [Full Text] [Related]

  • 13. Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
    Gauthier A, Martín-Escudero V, Moore L, Ferko N, de Sanjosé S, Pérez-Escolano I, Catalá-López F, Ferrer E, Bosch FX.
    Eur J Public Health; 2008 Dec 25; 18(6):674-80. PubMed ID: 18641420
    [Abstract] [Full Text] [Related]

  • 14. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY.
    Vaccine; 2008 Jul 29; 26(32):4080-93. PubMed ID: 18550229
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun 29; 16(89):91-4. PubMed ID: 17582921
    [Abstract] [Full Text] [Related]

  • 16. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 Jun 29; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 17. Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.
    Boot HJ, Wallenburg I, de Melker HE, Mangen MJ, Gerritsen AA, van der Maas NA, Berkhof J, Meijer CJ, Kimman TG.
    Vaccine; 2007 Aug 14; 25(33):6245-56. PubMed ID: 17630049
    [Abstract] [Full Text] [Related]

  • 18. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
    Brotherton JM.
    Vaccine; 2008 Jan 10; 26(2):250-6. PubMed ID: 18068276
    [Abstract] [Full Text] [Related]

  • 19. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL, Coutlée F, Ferenczy A.
    Public Health Genomics; 2009 Jan 10; 12(5-6):352-61. PubMed ID: 19684447
    [Abstract] [Full Text] [Related]

  • 20. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.